The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.
Letter to the Editor
I read the article on prescribing for people in custody1 with interest. It raised many valid points and covered several narcotics and other sedatives among high-risk medicines. I would like to draw attention to antihyperglycaemic drugs, especially insulin which requires expertise on site to monitor its use and potential misuse. This is more important for inmates with type 1 diabetes in high-security facilities who mostly do not have access to diabetic meals, and where food provided after hours is mostly not diabetes friendly. In my experience dealing with patients on insulin in custody is really challenging. Rigid schedules and limited availability of healthcare staff add to the complexity of this situation.
It is unfortunate that in spite of the high prevalence of diabetes in the community, especially in those who are disadvantaged, there is no specific policy on management of people with diabetes in custody.
Santosh K Chaubey
Staff specialist (Endocrinology)